CRI

Business Context and Reporting Period

Carter's, Inc. (CRI) filed its Form 10-Q for the fiscal quarter ended June 28, 2025. The Company is the largest branded marketer of young children's apparel in North America, operating through three segments: U.S. Retail, U.S. Wholesale, and International. The reporting period covers a 13-week quarter within a 53-week fiscal year ending January 3, 2026.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Decline: Operating income plummeted 89.7% year-over-year in Q2 to $4.0 million, and net income dropped 98.4% to $0.4 million. This was driven by a 200 basis point compression in gross margin and a 420 basis point increase in SG&A expenses as a percentage of sales.
• Revenue Growth: Consolidated net sales increased 3.7% in Q2, driven by higher unit volumes in U.S. Retail and strong performance in Canada and Mexico. However, YTD sales decreased 0.9% due to lower average selling prices and reduced traffic in U.S. Retail.
• Expense Increases: SG&A expenses rose 13.5% in Q2, attributed to operating model improvement costs ($6.6 million), leadership transition costs ($1.1 million), and higher performance-based compensation.
• Cash Flow Reversal: Operating cash flow turned negative for the first two quarters of 2025 ($8.3 million used), compared to $91.7 million provided in the prior year, primarily due to increased inventory purchases to mitigate tariff impacts and lower net income.

Guidance, Outlook, and Risks

• Tariff Impact: Management expects incremental tariffs on imports from China, Vietnam, and Indonesia to negatively impact pre-tax income by approximately $35 million in the second half of fiscal 2025. Annualized gross costs are estimated between $125 million and $150 million.
• Dividend Reduction: The Q2 dividend was reduced to $0.25 per share (down from $0.80 in Q1) to align with current profitability levels and anticipated tariff costs.
• Capital Allocation: The Company suspended open market share repurchases in the first two quarters of 2025. Remaining authorization capacity is $599.0 million.
• Impairment Testing: Due to new tariffs and stock price declines, the Company performed quantitative impairment tests on goodwill and tradename assets. No impairments were recorded, but the "Other International" reporting unit remains sensitive to changes in operating margins and revenue growth.
• Operating Model: The Company is investing in operating model improvements to enhance product development speed and responsiveness, with an additional $4–5 million in costs expected for the remainder of fiscal 2025.

Investor Verification Checklist

• Tariff Mitigation Strategy: Verify the effectiveness of pricing adjustments and supply chain diversification in offsetting the projected $35 million H2 2025 pre-tax income impact.
• Inventory Levels: Monitor inventory balances ($619.1 million) and days of supply to ensure the buildup for tariff hedging does not lead to future markdowns or obsolescence.
• U.S. Retail Traffic: Assess whether the Q2 improvement in U.S. Retail comparable sales (+2.2%) is sustainable given the broader decline in YTD traffic.
• SG&A Leverage: Track the trajectory of SG&A expenses as a percentage of sales to determine if operating model improvement costs are one-time or recurring.
• Liquidity Position: Confirm the sufficiency of the $843.1 million available credit facility and $338.2 million cash balance to fund operations amidst negative operating cash flow.